Professor and Chair, Department of Psychiatry, Boston University School of Medicine
Psychiatry
Dr. Domenic A. Ciraulo, MD
|
|
Give Review
Doctor Domenic A. Ciraulo, MD is an expert in the field of Psychiatry. He graduated from Georgetown University School of Medicine. Georgetown University School of Medicine is ranked 49/84 in Research/PrimaryCare. He received 13 awards: "America's Top Doctors", "Boston Magazine", "Listed in The Best Doctors in America", "Americas Top Psychiatrists", "Distinguished Fellow", "Marquis Whos Who in America", "Academic Keys Who's Who in Medical Sciences Education", "Distinguished Service Award", "Fellow", "Harry C. Solomon Essay Award", "Grieff Essay Award", "Regents Honor Award" and "Super Doctor". Domenic A. Ciraulo, MD is also a published MD. He has 101 paper published. The most recent paper is: The type IV phosphodiesterase inhibitors, Ro 20-1724 and rolipram, block the initiation of cocaine self-administration.
Publications
- Payment expectations for research participation among subjects who tell the truth, subjects who conceal information, and subjects who fabricate information.
- Mechanisms underlying sleep-wake disturbances in alcoholism: focus on the cholinergic pedunculopontine tegmentum.
- Bright light therapy for depression: A review of its effects on chronobiology and the autonomic nervous system.
- The effects of venlafaxine and cognitive behavioral therapy alone and combined in the treatment of co-morbid alcohol use-anxiety disorders.
- Concealment and fabrication by experienced research subjects.
- The Efficacy of Mirtazapine in the Treatment of Cocaine Dependence with Comorbid Depression.
- Effects of yoga versus walking on mood, anxiety, and brain GABA levels: a randomized controlled MRS study.
- Deep brain stimulation of the nucleus accumbens reduces ethanol consumption in rats.
- Deep brain stimulation of the nucleus accumbens shell attenuates cocaine priming-induced reinstatement of drug seeking in rats.
- Performance on the Stroop predicts treatment compliance in cocaine-dependent individuals.
- Early treatment response in alcohol dependence with extended-release naltrexone.
- Cerebellar gray matter volume correlates with duration of cocaine use in cocaine-dependent subjects.
- Reduced Plasma Nitric Oxide End Products in Cocaine-dependent Men.
- Zonisamide decreases ethanol intake in rats and mice.
- Yoga Asana sessions increase brain GABA levels: a pilot study.
- Effects of low dose cocaine on REM sleep in the freely moving rat.
- Clinicians on the front line: active management of depression and anxiety in primary care.
- Pharmacokinetics and pharmacodynamics of multiple sublingual buprenorphine tablets in dose-escalation trials.
- Safety and efficacy of GABAergic medications for treating alcoholism.
- Quetiapine for treatment of alcohol dependence.
- An open-label pilot study of methylphenidate in the treatment of cocaine dependent patients with adult attention deficit/hyperactivity disorder.
- Dose-ranging kinetics and behavioral pharmacology of naltrexone and acamprosate, both alone and combined, in alcohol-dependent subjects.
- Outcome predictors in substance use disorders.
- Low-dose risperidone as adjunctive therapy for irritable aggression in posttraumatic stress disorder.
- Videotaped cue for urge to drink alcohol.
- Use of bright light therapy among psychiatrists in massachusetts: an e-mail survey.
- A Double-Blind, Placebo-Controlled Trial Assessing the Efficacy of Varenicline Tartrate for Alcohol Dependence.
- Personality, family history, and alcohol use among older men: the VA Normative Aging Study.
- Benzodiazepine treatment of anxiety or insomnia in substance abuse patients.
- A benzodiazepine mood effect scale: reliability and validity determined for alcohol-dependent subjects and adults with a parental history of alcoholism.
- Adenosine agonists CGS 21680 and NECA inhibit the initiation of cocaine self-administration.
- Additive effects of intra-accumbens infusion of the cAMP-specific phosphodiesterase inhibitor, rolipram and cocaine on brain stimulation reward.
- Appetite suppressant drugs as inhibitors of human cytochromes P450: in vitro inhibition of P450-2D6 by D- and L-fenfluramine, but not phentermine.
- Functional magnetic resonance imaging of alprazolam-induced changes in humans with familial alcoholism.
- The type IV phosphodiesterase inhibitors, Ro 20-1724 and rolipram, block the initiation of cocaine self-administration.
- Risperidone effects on irritable aggression in posttraumatic stress disorder.
- Decreased EEG sensitivity to alprazolam in subjects with a parental history of alcoholism.
- Efficacy screening trials of paroxetine, pentoxifylline, riluzole, pramipexole and venlafaxine in cocaine dependence.
- Nefazodone treatment of cocaine dependence with comorbid depressive symptoms.
- Frontal lobe GABA levels in cocaine dependence: a two-dimensional, J-resolved magnetic resonance spectroscopy study.
- White matter hyperintensities in subjects with cocaine and opiate dependence and healthy comparison subjects.
- Improvement of physical health and quality of life of alcohol-dependent individuals with topiramate treatment: US multisite randomized controlled trial.
- Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial.
- Coronary arterial dissection: an unrecognized cause of myocardial infarction, with subsequent coronary arterial patency.
- Fatal hyperthermia following haloperidol therapy of sedative-hypnotic withdrawal.
- Cocaine Rapid Efficacy Screening Trials (CREST): lessons learned.
- Prefrontal GABA levels in cocaine-dependent subjects increase with pramipexole and venlafaxine treatment.
- A double-blind, placebo-controlled trial of reserpine for the treatment of cocaine dependence.
- A double-blind, placebo-controlled trial of tiagabine for the treatment of cocaine dependence.
- Topiramate for treating alcohol dependence: a randomized controlled trial.
- Drug interactions involving psychotropic drugs.
- Recurrent myocardial infarction and angina in a woman with normal coronary angiograms.
- Cocaine drug-drug interactions.
- Benzodiazepine receptor binding response to acute and chronic stress is increased in aging animals.
- Benzodiazepine response and receptor binding after chronic ethanol ingestion in a mouse model.
- Fluoxetine drug-drug interactions: I. Antidepressants and antipsychotics.
- Fluoxetine drug-drug interactions. II.
- Effect of five-consecutive-day exposure to an anxiogenic stressor on sleep-wake activity in rats.
- The diagnosis and treatment of panic disorder in alcoholics: three cases.
- Intravenous pharmacokinetics of 2-hydroxyimipramine in alcoholics and normal controls.
- The relationship of alprazolam dose to steady-state plasma concentrations.
- Can disulfiram (Antabuse) be safely co-administered with the monoamine oxidase inhibitor (MAOI) antidepressants? Despite the ability of the major metabolite of disulfi...
- A Gompertz age-specific mortality rate model of aging: modification by dietary restriction in rats.
- A Gompertz age-specific mortality rate model of aging, hormesis, and toxicity: dose-response studies.
- Parental alcoholism as a risk factor in benzodiazepine abuse: a pilot study.
- Abuse potential of benzodiazepines.
- Pharmacokinetics and clinical effects of alprazolam following single and multiple oral doses in patients with panic disorder.
- Critical review of liability for benzodiazepine abuse among alcoholics.
- A Gompertz age-specific mortality rate model of aging, hormesis, and toxicity: fixed-dose studies.
- Pharmacokinetic mechanisms of ethanol-psychotropic drug interactions.
- Clinical pharmacokinetics of imipramine and desipramine in alcoholics and normal volunteers.
- Abuse liability and clinical pharmacokinetics of alprazolam in alcoholic men.
- Pharmacokinetic interaction of disulfiram and antidepressants.
- Physostigmine test in the rabbit syndrome and tardive dyskinesia.
- Effect of age and sex on disposition of desmethyldiazepam formed from its precursor clorazepate.
- Steady-state plasma desmethyldiazepam during long-term clorazepate use: effects of antacids.
- Abuse potential of halazepam and of diazepam in patients recently treated for acute alcohol withdrawal.
- Dexamethasone suppression test in recently detoxified alcoholics: clinical implications.
- Transmural myocardial infarction with normal coronary angiograms and with single vessel coronary obstruction. Clinical-angiographic features and five-year follow-up.
- Clobazam kinetics: intrasubject variability and effect of food on adsorption.
- Imipramine disposition in alcoholics.
- Lithium and marijuana.
- Tricyclic antidepressants in the treatment of depression associated with alcoholism.
- A placebo-controlled trial of selegiline (L-deprenyl) in the treatment of tardive dyskinesia.
- Mitral valve fluttering; an echocardiographic feature of left atrial myxoma.
- Myocardial infarction in pregnancy associated with a coronary artery thrombus.
- Inexcitable right ventricle and bilateral bundle branch block in Uhl''s disease.
- Alprazolam pharmacokinetics, metabolism, and plasma levels: clinical implications.
- Alprazolam and benzodiazepine dependence.
- Liability to alprazolam abuse in daughters of alcoholics.
- Alterations in pharmacodynamics of anxiolytics in abstinent alcoholic men: subjective responses, abuse liability, and electroencephalographic effects of alprazolam, di...
- Outpatient cardiac catheterization.
- The anticonvulsant zonisamide reduces ethanol self-administration by risky drinkers.
- Open label trial of the tolerability and efficacy of zonisamide in the treatment of alcohol dependence.
- The effects of levetiracetam on alcohol consumption in alcohol-dependent subjects: an open label study.
- A placebo-controlled trial of trihexyphenidyl in unmedicated patients with schizophrenia.
- Modafinil for the treatment of cocaine dependence.
- Relationship between medication adherence and treatment outcomes: the COMBINE study.
- Retrospective analyses of pooled data from CREST I and CREST II trials for treatment of cocaine dependence.
- Differences between daily smokers, chippers, and nonsmokers with co-occurring anxiety and alcohol-use disorders.
Schools
Georgetown University
Institute Living
Mass Mntl Health Center
Harvard Med School
Doctors Specialties
- Addiction Psychiatry
- Psychiatry
Accepted Insurances
Awards
- America's Top Doctors
- Boston Magazine
- Listed in The Best Doctors in America
- America’s Top Psychiatrists
- Distinguished Fellow
- Marquis Who’s Who in America
- Academic Keys Who's Who in Medical Sciences Education
- Distinguished Service Award
- Fellow
- Harry C. Solomon Essay Award
- Grieff Essay Award
- Regents Honor Award
- Super Doctor
Education
-
Harvard Medical School -
Georgetown University School of Medicine
Hospital
-
Massachusetts General Hospital -
Boston Medical Center
Helpful Reviews
Similar Doctors
|
|
Dr. Lily A. Awad, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shamim H. Nejad, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Fadi T. Maalouf, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John R. Peteet, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Giuseppe J. Raviola, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William R. Beardslee, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Justin B. Smith, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Brian Hurley, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Leah K. Bauer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sepideh S. Aram, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John J. Mooney, MD |
|
|
Dr. Mohammed A. Issa, MD
This Doctor is OpenDoctor Recommended.
|